Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - RESEARCH & DEVELOPMENT
Research & Development IKT - Inhibikase Therapeutics, Inc.
17.2 M
LAST VALUE
19.58%
2 YEAR CAGR
46.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR